Arginyl-tRNA-protein transferase 1 (ATE1) promotes melanoma cell growth and migration

Ikrame Lazar, Bertrand Fabre, Yongmei Feng, Ali Khateb, Philippe Frit, Anna Kashina, Tongwu Zhang, Emily Avitan-Hersh, Hyungsoo Kim, Kevin Brown, Ivan Topisirovic, Ze’ev A. Ronai

Research output: Contribution to journalArticlepeer-review


Arginyl-tRNA-protein transferase 1 (ATE1) catalyses N-terminal protein arginylation, a post-translational modification implicated in cell migration, invasion and the cellular stress response. Herein, we report that ATE1 is overexpressed in NRAS-mutant melanomas, while it is downregulated in BRAF-mutant melanomas. ATE1 expression was higher in metastatic tumours, compared with primary tumours. Consistent with these findings, ATE1 depletion reduced melanoma cell viability, migration and colony formation. Reduced ATE1 expression also affected cell responses to mTOR and MEK inhibitors and to serum deprivation. Among putative ATE1 substrates is the tumour suppressor AXIN1, pointing to the possibility that ATE1 may fine-tune AXIN1 function in melanoma. Our findings highlight an unexpected role for ATE1 in melanoma cell aggressiveness and suggest that ATE1 constitutes a potential new therapeutic target.

Original languageEnglish
Pages (from-to)1468-1480
Number of pages13
JournalFEBS Letters
Issue number11
StatePublished - Jun 2022
Externally publishedYes


  • ATE1
  • AXIN1
  • cancer
  • cell migration
  • cell viability
  • melanoma


Dive into the research topics of 'Arginyl-tRNA-protein transferase 1 (ATE1) promotes melanoma cell growth and migration'. Together they form a unique fingerprint.

Cite this